Rucaparib phosphate
PARP Inhibitor
Product Specifications
Background
Rucaparib is a PARP1, PARP2 and PARP3 inhibitor and inhibits PARP-mediated DNA repair (1). It is being developed for ovarian, prostate and bladder cancers (2, 3).
Product Name Alternative
8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one, phosphate; AG-14699; PF01367338
UNSPSC
41116105
Source
Synthetic
Purity
>98% (HPLC); NMR (Conforms)
Weight
0.005
Format
Yellow powder
Solubility
May be dissolved in DMSO (25 mg/ml)
Molecular Formula
C19H18FN3O * H3PO4
Molecular Weight
421.4
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. https://pubchem.ncbi.nlm.nih.gov/compound/rucaparib 2. Dockery L.E., Gunderson C.C., and Moore K.N. (2017) Onco Target Ther. 10: 3029-3037. 3. Syed Y.Y. (2017) Drugs. 77(5): 585-592.
CAS Number
459868-92-9
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items